Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CFSAN Beefs Up Ingredient Safety Oversight With Risk Assessment Software

This article was originally published in The Tan Sheet

Executive Summary

FDA's Center for Food Safety and Applied Nutrition includes dietary supplement firms among the businesses it expects to benefit from software it developed to detect food product manufacturing facilities' vulnerabilities to biological, chemical or radiological attacks

You may also be interested in...



Supplement GMPs Stress Responsibility, Put Firms In Driver’s Seat For Testing

The dietary supplement good manufacturing practices final rule provides "a very flexible framework for required testing," said Vasilios H. Frankos, director of the dietary supplement programs division for FDA's Center for Food Safety and Applied Nutrition

Toothpaste Recalls Bear Out FDA Warning On DEG Contamination

Firms in Florida, New Jersey and Puerto Rico initiated recalls of toothpaste products possibly contaminated with diethylene glycol after FDA warned consumers not to use toothpaste labeled as made in China and issued an import alert to prevent toothpaste containing toxic DEG from entering the country

FTC Views Testimonials As Efficacy Claims, Senior Attorney Warns

The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel